SCHEMBL5690208

SCHEMBL5690208

CC(=O)N(CCCc1ccccc1)[C@H]1CC[C@H](c2ccc(OCc3ccccc3)cc2)CC1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 1/20 0.50
ALOX5 P09917 4/20 0.49
S1PR1 P21453 1/20 0.47
PTGS1 P23219 1/20 0.46
PTGS2 P35354 1/20 0.46
LTB4R Q15722 1/20 0.45
LTB4R2 Q9NPC1 1/20 0.45
BCHE P06276 1/20 0.45
FFAR4 Q5NUL3 3/20 0.45
MAOB P27338 1/20 0.44
LTA4H P09960 1/20 0.44
EPHX2 P34913 1/20 0.44
FFAR1 O14842 1/20 0.43
AGTR2 P50052 1/20 0.43
LIPG Q9Y5X9 1/20 0.43
KCNH2 Q12809 1/20 0.43
TSPO P30536 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5690205 1.00 MRGPRX4 (0.50) MRGPRX4ALOX5S1PR1PTGS1PTGS2
SCHEMBL6486622 0.88 AGTR2 (0.47) MAOBAGTR2
SCHEMBL6486620 0.88 AGTR2 (0.47) MAOBAGTR2
SCHEMBL5691624 0.83 BCHE (0.49) MRGPRX4ALOX5LTB4RLTB4R2BCHE
SCHEMBL5691626 0.83 BCHE (0.49) MRGPRX4ALOX5LTB4RLTB4R2BCHE
SCHEMBL5690183 0.81 BCHE (0.50) MRGPRX4ALOX5S1PR1BCHELTA4H
SCHEMBL5690181 0.81 BCHE (0.50) MRGPRX4ALOX5S1PR1BCHELTA4H
SCHEMBL6488483 0.78 OPRM1 (0.40) S1PR1
SCHEMBL6488479 0.78 OPRM1 (0.40) S1PR1
SCHEMBL5690171 0.78 BCHE (0.47) MRGPRX4ALOX5LTB4RLTB4R2BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0982026-B1 Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers HOFFMANN LA ROCHE (CH) 2006-05-17 EP disclosed
US-6184236-B1 Method of treating a neurodegenerative disease by administering an aryl-cyclohexylamine derivative HOFFMANN-LA ROCHE INC. 2001-02-06 US disclosed
EP-0982026-A2 Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers F. HOFFMANN-LA ROCHE AG (CH) 2000-03-01 EP disclosed